CHARLES RIVER LABORATORIES INTERNATIONAL

charles-river-laboratories-international-logo

Charles River Laboratories International, Inc. provides solutions that accelerate the drug discovery and development process, including research models and associated services, and outsourced preclinical services. Segments The company has two segments: Research Models and Services (RMS) and Preclinical Services (PCS), which includes Phase I clinical services. RESEARCH MODELS AND SERVICES (RMS) The company supplies research models to the drug development industry. With approximately 150 different... strains the company engages in the production and sale of research models, principally genetically and virally defined purpose-bred rats and mice. It also provides various related services that are designed to assist customers in supporting the use of research models in drug development. With multiple facilities located on three continents (North America, Europe and Asia (Japan)), the company maintains production centers, including a total of approximately 180 barrier rooms or isolator facilities located near its customers. RMS segment comprises Research Models, Research Model Services, and other related products and services
#SimilarOrganizations #People #Financial #Event #Website #More

CHARLES RIVER LABORATORIES INTERNATIONAL

Social Links:

facebook

Facebook

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1947-01-01

Address:
Wilmington, Massachusetts, United States

Country:
United States

Website Url:
http://www.criver.com

Total Employee:
5001+

Status:
Active

Contact:
(781)222-6000

Total Funding:
1.53 B USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager WordPress Font Awesome Domain Not Resolving Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box Euro


Similar Organizations

epivax-logo

EpiVax

EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.

jaber-ibn-hayyan-pharmaceutical-logo

Jaber Ibn Hayyan Pharmaceutical

Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.


Current Advisors List

craig-thompson_image

Craig Thompson Member of the Board of Directors @ Charles River Laboratories International
Board_member

robert-bertolini_image

Robert Bertolini Member of the Board of Directors @ Charles River Laboratories International
Board_member
2011-01-01

Current Employees Featured

jacob-mcdaniel_image

Jacob McDaniel
Jacob McDaniel Director of Experience Design @ Charles River Laboratories International
Director of Experience Design
2022-02-01

not_available_image

William D. Barbo
William D. Barbo Executive Vice President & Chief Commercial Officer @ Charles River Laboratories International
Executive Vice President & Chief Commercial Officer
1982-06-01

chris-lowrie_image

Chris Lowrie
Chris Lowrie Senior Director, Lab Sciences @ Charles River Laboratories International
Senior Director, Lab Sciences
2020-06-01

not_available_image

Anja Tessarz
Anja Tessarz Scientific Specialist Viral Clearance @ Charles River Laboratories International
Scientific Specialist Viral Clearance
2020-01-01

virginia-m-wilson_image

Virginia M. Wilson
Virginia M. Wilson Director @ Charles River Laboratories International
Director
2019-10-01

not_available_image

Gina Mullane
Gina Mullane Sr. Vice President Client Experience and Chief Marketing Officer @ Charles River Laboratories International
Sr. Vice President Client Experience and Chief Marketing Officer
2016-06-01

greg-mason_image

Greg Mason
Greg Mason Sr. Director, Global Category Procurement, Lab Operations @ Charles River Laboratories International
Sr. Director, Global Category Procurement, Lab Operations
2019-11-01

tiffany-granacki_image

Tiffany Granacki
Tiffany Granacki Director, Sales and Marketing @ Charles River Laboratories International
Director, Sales and Marketing
2022-04-01

bill-jefferson_image

Bill Jefferson
Bill Jefferson Business Development Director - Safety Assessment @ Charles River Laboratories International
Business Development Director - Safety Assessment
2018-07-01

james-c-foster_image

James C. Foster
James C. Foster Chairman, President and Chief Executive Officer @ Charles River Laboratories International
Chairman, President and Chief Executive Officer
1976-04-01

Founder


not_available_image

Henry Foster

Stock Details


Company's stock symbol is NYSE:CRL

Acquisitions List

Date Company Article Price
2022-04-06 Explora BioLabs Explora BioLabs acquired by Charles River Laboratories International 295 M USD
2021-05-17 Vigene Biosciences Vigene Biosciences acquired by Charles River Laboratories International 292.5 M USD
2021-03-31 Retrogenix Retrogenix acquired by Charles River Laboratories International N/A
2021-02-17 Cognate BioServices Cognate BioServices acquired by Charles River Laboratories International 875 M USD
2020-12-31 Distributed Bio Distributed Bio acquired by Charles River Laboratories International 83 M USD
2020-08-06 Cellero Cellero acquired by Charles River Laboratories International 38 M USD
2019-12-16 HemaCare HemaCare acquired by Charles River Laboratories International N/A
2019-02-13 CiToxLAB CiToxLAB acquired by Charles River Laboratories International 448 M EUR
2018-02-13 MPI Research MPI Research acquired by Charles River Laboratories International 800 M USD
2018-01-11 KWS BioTest KWS BioTest acquired by Charles River Laboratories International N/A

Investors List

national-institutes-of-health_image

National Institutes of Health

National Institutes of Health investment in Grant - Charles River Laboratories International

Investments List

Date Company Article Money raised
2022-06-02 Vernal Biosciences Charles River Laboratories International investment in Venture Round - Vernal Biosciences 21 M USD
2022-05-19 Deciphex Charles River Laboratories International investment in Series B - Deciphex 11.5 M USD
2021-11-09 PathoQuest Charles River Laboratories International investment in Series B - PathoQuest 15 M EUR
2021-11-05 bit.bio Charles River Laboratories International investment in Series B - bit.bio 103 M USD
2019-09-06 PathoQuest Charles River Laboratories International investment in Venture Round - PathoQuest 8 M EUR
1997-01-01 Aspect Medical Systems Charles River Laboratories International investment in Venture Round - Aspect Medical Systems 17.5 M USD

Newest Events participated

chemical-industry-regulations-2017_event_image Participated in Chemical Industry Regulations 2017 on 2017-09-05 as sponsor

bioprocess-international-european-summit-2017_event_image Participated in BioProcess International European Summit 2017 on 2017-04-25 as exhibitor

viral-safety-2017_event_image Participated in Viral Safety 2017 on 2017-04-25 as sponsor

cell-line-development-engineering-2017_event_image Participated in Cell Line Development & Engineering 2017 on 2017-04-24 as exhibitor

Official Site Inspections

http://www.criver.com Semrush global rank: 252.54 K Semrush visits lastest month: 273.61 K

  • Host name: ec2-52-54-40-78.compute-1.amazonaws.com
  • IP address: 52.54.40.78
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Charles River Laboratories International" on Search Engine

dfkcompany.com © 2022. All rights reserved